deltatrials
Terminated PHASE2 INTERVENTIONAL 1-arm NCT02347163

Pre-operative Zoledronate in Triple Negative Breast Cancer

A Multicenter, Single-arm, Phase II Study to Evaluate the Activity of Pre-operative Zoledronate in Triple Negative Breast Cancer Patients, According to p53 Level

Sponsor: Associazione Italiana per la Ricerca sul Cancro

Conditions Breast Cancer
Interventions Zoledronate
Updated 8 times since 2017 Last updated: Nov 5, 2018 Started: Feb 3, 2015 Primary completion: Jun 8, 2018 Completion: Jun 8, 2018
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

The study stopped prematurely due to the low accrual rate

Other Breast Cancer trials with similar outcome

Browse all Breast Cancer trials

Listed as NCT02347163, this PHASE2 trial focuses on Breast Cancer and remains terminated or withdrawn. Sponsored by Associazione Italiana per la Ricerca sul Cancro, it has been updated 8 times since 2015, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotRecruiting~Jun 2018 – ~Nov 2018 · 5 months · monthly snapshotRecruiting~Nov 2018 – ~Dec 2018 · 30 days · monthly snapshotTerminated~Dec 2018 – ~Jan 2021 · 25 months · monthly snapshotTerminated~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotTerminated~Sep 2025 – present · 11 months · monthly snapshotTerminated

Change History

8 versions recorded

  1. Sep 2025 — Present [monthly]

    Terminated PHASE2

  2. Sep 2024 — Sep 2025 [monthly]

    Terminated PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE2

  4. Jan 2021 — Jul 2024 [monthly]

    Terminated PHASE2

  5. Dec 2018 — Jan 2021 [monthly]

    Terminated PHASE2

▶ Show 3 earlier versions

  1. Nov 2018 — Dec 2018 [monthly]

    Terminated PHASE2

    Status: Recruiting → Terminated

  2. Jun 2018 — Nov 2018 [monthly]

    Recruiting PHASE2

  3. Jan 2017 — Jun 2018 [monthly]

    Recruiting PHASE2

    First recorded

Feb 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Associazione Italiana per la Ricerca sul Cancro
  • Mario Negri Institute for Pharmacological Research
Data source: Mario Negri Institute for Pharmacological Research

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations